MPG.eBooks - Search Results

1

Clinical review report: Brolucizumab (Beovu) (Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular degeneration (AMD)

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

2

Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

3

Pharmacoeconomic review report: Burosumab (Crysvita), Kyowa Kirin Limited : indication : for the treatment of x-linked hypophosphatemia in adult and pediatric patients one year of...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

4

Clinical review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

5

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

6

Clinical review report: Tocilizumab (Actemra) (Hoffmann-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

7

Clinical review report: Burosumab (Crysvita) (Kyowa Kirin limited) : indication: for the treatment of x-linked hypophosphatemia in adult and pediatric patients one year of age and...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

8

Clinical review report: Tocilizumab (Actemra) (Hoffmann-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

9

Pharmacoeconomic review report: Tocilizumab (Actemra) (Hoffman-La Roche Limited)

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

10

Sarilumab (Kevzara)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

11

CADTH Canadian Drug Expert Committee recommendation: Brolucizumab (Beovu -- Novartis Pharmaceuticals Canada Inc.) : indication : treatment of neovascular (wet) age-related macular...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

12

CADTH Canadian Drug Expert Committee recommendation: Vedolizumab (Entyvio -- Takeda Canada Inc.) : indication : for the treatment of adult patients with moderately to severely acti...

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

13

HPV testing for primary cervical cancer screening : recommendations report

Published 2019

CADTH

Subjects: “...Canada...”

Read Now

14

CADTH Canadian drug expert committee recommendation: Burosumab (Crysvita -- Kyowa Kirin Limited) : indication : treatment of x-linked hypophosphatemia

Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

15

HPV testing for primary cervical cancer screening : recommendations report

Published 2019

CADTH

Subjects: “...Canada...”

Read Now

16

Future Horizons : Canadian Digital Humanities

by Barrett, Paul
Published 2023

University of Ottawa Press / Les Presses de l’Université d’Ottawa

Subjects: “...Canada...”

Read Now

17

Pharmacoeconomic review report: Ixekizumab (Taltz) (Eli Lilly Canada Inc.) : indication : treatment of adult patients with active psoriatic arthritis who have responded inadequatel...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

18

Patient group input submissions: Ocrelizumab (Ocrevus) (Hoffmann-La Roche Limited)

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

19

CADTH Canadian Drug Expert Committee final recommendation: Sarilumab (Kevzara -- Sanofi Genzyme) : indication: rheumatoid arthritis

Published 2017

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Read Now

20

Masks for prevention of influenza transmission in acute and long-term care settings : a review of clinical effectiveness, cost-effectiveness and guidelines

by Marchand, Dave K., Argáez, Charlene
Published 2020

Canadian Agency for Drugs and Technologies in Health

Subjects: “...Canada...”

Narrow Search